Proteus genomic island 1 (PGI1), a new resistance genomic island from two Proteus mirabilis French clinical isolates

Journal of Antimicrobial Chemotherapy

Volumn 69, Issue 12, 2014, Pages 3216-3220

  Siebor, Eliane ^a   Neuwirth, Catherine ^a  

^a DIJON UNIVERSITY HOSPITAL   (France)

Author keywords

Antimicrobial resistance; Human isolates; Integrons; Transposons

Indexed keywords

AMOXICILLIN; DNA FRAGMENT; DOXYCYCLINE; GENTAMICIN; KANAMYCIN; SPECTINOMYCIN; STREPTOMYCIN; SULFONAMIDE; TOBRAMYCIN; ANTIINFECTIVE AGENT; BACTERIAL DNA;

AADA2 GENE; AADB GENE; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; APHA1B GENE; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CHROMOSOME; GENE MAPPING; GENE SEQUENCE; GENE STRUCTURE; GENETIC RECOMBINATION; GENOMIC ISLAND; HUMAN; INTEGRON; MULTIDRUG RESISTANCE; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PROTEUS GENOMIC ISLAND 1; PROTEUS MIRABILIS; SALMONELLA; SALMONELLA ENTERICA SEROVAR HEIDELBERG; STRA GENE; STRB GENE; TETA GENE; TRANSPOSON; TRME GENE; CHEMISTRY; DNA SEQUENCE; DRUG EFFECTS; FRANCE; GENE ORDER; GENETICS; ISOLATION AND PURIFICATION; MICROBIOLOGY; MOLECULAR GENETICS; PROTEUS INFECTION;

ANTI-BACTERIAL AGENTS; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; FRANCE; GENE ORDER; GENES, BACTERIAL; GENOMIC ISLANDS; HUMANS; MOLECULAR SEQUENCE DATA; PROTEUS INFECTIONS; PROTEUS MIRABILIS; SEQUENCE ANALYSIS, DNA;

EID: 84934300829     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dku314     Document Type: Article

References (18)

1. Boyd D, Peters GA, Cloeckaert A et al. Complete nucleotide sequence of a 43-kilobase genomic island associated with the multidrug resistance region of Salmonella enterica serovar TyphimuriumDT104 and its identification in phage type DT120 and serovar Agona. J Bacteriol 2001; 183: 5725-32.
2. Levings RS, Lightfoot D, Partridge SR et al. The genomic island SGI1, containing the multiple antibiotic resistance region of Salmonella enterica serovar Typhimurium DT104 or variants of it, is widely distributed in other S. enterica serovars. J Bacteriol 2005; 187: 4401-9.
3. Hall RM. Salmonella genomic islands and antibiotic resistance in Salmonella enterica. Future Microbiol 2010; 5: 1525-38.
4. Levings RS, Partridge SR, Djordjevic SP et al. SGI1-K, a variant of the SGI1 genomic island carrying a mercury resistance region, in Salmonella enterica serovar Kentucky. Antimicrob Agents Chemother 2007; 51: 317-23.
5. Levings RS, Djordjevic SP, Hall RM. SGI2, a relative of Salmonella genomic island SGI1 with an independent origin. Antimicrob Agents Chemother 2008; 52: 2529-37.
6. Doublet B, Boyd D, Mulvey MR et al. The Salmonella genomic island 1 is an integrative mobilizable element. Mol Microbiol 2005; 55: 1911-24.
7. Doublet B, Golding GR, Mulvey MR et al. Potential integration sites of the Salmonella genomic island 1 in Proteus mirabilis and other bacteria. J Antimicrob Chemother 2007; 59: 801-3.
8. Ahmed AM, Hussein AI, Shimamoto T. Proteus mirabilis clinical isolate harbouring a new variant of Salmonella genomic island 1 containing the multiple antibiotic resistance region. J Antimicrob Chemother 2007; 59: 184-90.
9. Boyd DA, Shi X, Hu QH et al. Salmonella genomic island 1 (SGI1), variant SGI1-I, and new variant SGI1-O in Proteus mirabilis clinical and food isolates from China. Antimicrob Agents Chemother 2008; 52: 340-4.
10. Doublet B, Poirel L, Praud K et al. European clinical isolate of Proteus mirabilis harbouring the Salmonella genomic island 1 variant SGI1-O. J Antimicrob Chemother 2010; 65: 2260-2.
11. Bi S, Yan H, Chen M et al. New variant Salmonella genomic island 1-U in Proteus mirabilis clinical and food isolates from South China. J Antimicrob Chemother 2011; 66: 1178-9.
12. Siebor E, Neuwirth C. The new variant of Salmonella genomic island 1 (SGI1-V) from a Proteus mirabilis French clinical isolate harbours blaVEB-6 and qnrA1 in the multiple antibiotic resistance region. J Antimicrob Chemother 2011; 66: 2513-20.
13. Siebor E, Neuwirth C. Emergence of Salmonella genomic island 1 (SGI1) among Proteus mirabilis clinical isolates in Dijon, France. J Antimicrob Chemother 2013; 68: 1750-6.
14. Neuwirth C, Siebor E, Pechinot A et al. Evidence of in vivo transfer of a plasmid encoding the extended-spectrum b-lactamase TEM-24 and other resistance factors among different members of the family Enterobacteriaceae. J Clin Microbiol 2001; 39: 1985-8.
15. Brown HJ, Stokes HW, Hall RM. The integrons In0, In2, and In5 are defective transposon derivatives. J Bacteriol 1996; 178: 4429-37.
16. Partridge SR, Hall RM. The IS1111 family members IS4321 and IS5075 have subterminal inverted repeats and target the terminal inverted repeats of Tn21 family transposons. J Bacteriol 2003; 185: 6371-84.
17. Partridge SR, Hall RM. Complex multiple antibiotic and mercury resistance region derived from the r-det of NR1 (R100). Antimicrob Agents Chemother 2004; 48: 4250-5.
18. Petrovski S, Stanisich VA. Tn502 and Tn512 are res site hunters that provide evidence of resolvase-independent transposition to random sites. J Bacteriol 2010; 192: 1865-74.